Results 211 to 220 of about 78,373 (263)

The protective effect of resveratrol on lupus nephritis mice by up-regulating Sirt1. [PDF]

Iran J Basic Med Sci
Zhao Y, Cai Y, Chen J, Yang XY.
europepmc   +1 more source

Dosimetric comparison between brachytherapy and MR-Linac as a boost modality for locally advanced cervical cancer. [PDF]

Clin Transl Radiat Oncol
van Noortwijk R, Kroon PS, van Vliet-van den Ende KM, Brondijk EH, Sikkes GG, Kotte ANTJ, Jürgenliemk-Schulz IM, van der Leij F, van Lier ALHMW.   +8 more
europepmc   +1 more source

Antiretroviral Activity, Pharmacokinetics, and Safety of MK-8527, an Oral Nucleoside Reverse Transcriptase Translocation Inhibitor, in Adults With HIV-1 Who Had Not Previously Taken Antiretroviral Agents: Results From 2 Open-Label, Phase 1 Studies. [PDF]

Clin Infect Dis
Carstens RP, Kapoor Y, Vargo RC, Bhattacharyya A, Garrett G, Cilissen C, Adedoyin A, Zang X, Denef JF, Leyssens C, Reynders T, Preotescu L, Kaplan R, Rassool M, Lombaard J, Streinu-Cercel A, Matthews RP, Stoch SA, Iwamoto M, Gillespie GL.   +19 more
europepmc   +1 more source

Spinal Microglial TLR7 Activation Drives Hyperalgesia in a Lupus Mouse Model via Upregulation of IL-1β, IL-18, and Cav2.2 and Enhanced Glutamatergic Synaptic Activity. [PDF]

Cells
Bipin S, Viatchenko-Karpinski V, Li C, Lim S, Weng HR.   +4 more
europepmc   +1 more source

Global Regulatory Mandates as Drivers for Advanced Chemical Analysis in Food Safety. [PDF]

Foods
Guo L, Dong X, Zhou H, Liu Z, Xiong X.
europepmc   +1 more source

Exosomal immune decoy integrates cfDNA scavenging and mTOR inhibition for synergistic lupus nephritis therapy. [PDF]

Theranostics
Zhu M, Xu Q, Tang Z, Wang Z, Zhu H, Sun L.   +5 more
europepmc   +1 more source

Quantifying setup uncertainty between computed tomography guidance and magnetic resonance guidance in intramuscular metastases radiotherapy. [PDF]

J Appl Clin Med Phys
Salzillo T, Prajapati S, Yu ZH, Zhao Y, Lim TY, Wang H, Wang XA, Chen X, Kudchadker R, Lee B, Sobremonte A, Farooqi AS, Mitra D, Bishop A, Tang C, Yang J.   +15 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Voluntary consumption of cyclophosphamide by nondeprived Mrl-lpr/lpr and Mrl +/+ mice

Pharmacology Biochemistry and Behavior, 1990
Cyclophosphamide dissolved in several dilutions of chocolate milk was presented for 20 hr daily to nondeprived, symptomatic, autoimmune Mrl-lpr/lpr and asymptomatic Mrl +/+ mice. In the absence of cyclophosphamide, daily consumption was inversely related to the concentration of the chocolate milk solutions and increased from the first to the fourth day
L J, Grota, R, Ader, J A, Moynihan, N, Cohen   +3 more
openaire   +2 more sources

Comparison of wasting syndrome in [MRL lprlpr-MRL+/+] chimera and graft versus host disease in [B10.D2-BALBc] chimera and an attempt to transfer the wasting syndrome in [MRL lprlpr-MRL+/+] chimera to MRL+/+ mice

Journal of Dermatological Science, 1993
Abstract We compared the findings in the wasting syndrome seen in [ MRL lpr lpr → MRL +/+ ] chimeras with those of chronic graft versus host disease (GVHD) in [ B10.D2 → BALB c ] chimeras. BALB c mice were lethally irradiated and administered B10.D2 spleen and bone marrow cells.
Michiko Aihara, Hiroshi Nakajima
openaire   +1 more source